Drug Information

Drug General Information
Drug ID
D0TT5K
Former ID
DIB016726
Drug Name
MDL-27531
Synonyms
4-Methyl-5-(methylsulfonyl)-3-phenyl-1,2,4-triazole
Drug Type
Small molecular drug
Indication Epilepsy [ICD10:G40] Phase 1 [526961]
Formula
C10H11N3O2S
Canonical SMILES
CN1C(=NN=C1S(=O)(=O)C)C2=CC=CC=C2
InChI
1S/C10H11N3O2S/c1-13-9(8-6-4-3-5-7-8)11-12-10(13)16(2,14)15/h3-7H,1-2H3
InChIKey
DPGDRICHXKQXEN-UHFFFAOYSA-N
CAS Number
CAS 116850-44-3
PubChem Compound ID
164013
PubChem Substance ID
10255318, 14798290, 46238308, 50056994, 51631279, 103140305, 103195032, 113453010, 117630853, 121363821, 123397840, 125699111, 127767370, 135118947, 141672121, 162271987, 162778315, 166667544, 218945134, 224124190, 227183383, 249755910
Target and Pathway
Target(s) Glycine receptor Target Info Modulator [526961]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Ligand-gated ion channel transport
WikiPathways Iron uptake and transport
References
Ref 526961MDL 27,531 reduces spontaneous hindlimb contractions in rats with chronic transections of the spinal cord. Neurosci Lett. 1992 Nov 23;147(1):101-5.
Ref 526961MDL 27,531 reduces spontaneous hindlimb contractions in rats with chronic transections of the spinal cord. Neurosci Lett. 1992 Nov 23;147(1):101-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.